JPWO2022177029A1 - - Google Patents
Info
- Publication number
- JPWO2022177029A1 JPWO2022177029A1 JP2023500976A JP2023500976A JPWO2022177029A1 JP WO2022177029 A1 JPWO2022177029 A1 JP WO2022177029A1 JP 2023500976 A JP2023500976 A JP 2023500976A JP 2023500976 A JP2023500976 A JP 2023500976A JP WO2022177029 A1 JPWO2022177029 A1 JP WO2022177029A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021026585 | 2021-02-22 | ||
| JP2021026585 | 2021-02-22 | ||
| JP2021106076 | 2021-06-25 | ||
| JP2021106076 | 2021-06-25 | ||
| JP2021165803 | 2021-10-07 | ||
| JP2021165803 | 2021-10-07 | ||
| PCT/JP2022/007397 WO2022177029A1 (ja) | 2021-02-22 | 2022-02-22 | セレノネインを含む、covid19治療又は予防薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022177029A1 true JPWO2022177029A1 (https=) | 2022-08-25 |
| JPWO2022177029A5 JPWO2022177029A5 (https=) | 2024-12-24 |
| JP7837513B2 JP7837513B2 (ja) | 2026-03-31 |
Family
ID=82931986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023500976A Active JP7837513B2 (ja) | 2021-02-22 | 2022-02-22 | セレノネインを含む、covid19治療又は予防薬 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250352517A1 (https=) |
| JP (1) | JP7837513B2 (https=) |
| TW (1) | TWI911391B (https=) |
| WO (1) | WO2022177029A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115737675B (zh) * | 2022-11-28 | 2024-03-08 | 安徽农业大学 | 氧化型硒代硫酸钠的制备及其在治疗冠状病毒感染中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11504355B2 (en) * | 2018-03-05 | 2022-11-22 | Mironova Innovations, Llc | Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms |
-
2022
- 2022-02-22 US US18/278,142 patent/US20250352517A1/en active Pending
- 2022-02-22 JP JP2023500976A patent/JP7837513B2/ja active Active
- 2022-02-22 WO PCT/JP2022/007397 patent/WO2022177029A1/ja not_active Ceased
- 2022-02-22 TW TW111106368A patent/TWI911391B/zh active
Non-Patent Citations (4)
| Title |
|---|
| CHEN L.R. ET AL.: "Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 15, JPN6021032914, 2005, pages 3058 - 3062, ISSN: 0005728143 * |
| PARK J.Y.ET AL.: "Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases", BIOORGANIC AND MEDICINAL CHEMISTRY, vol. 20, JPN6021032915, 2012, pages 5928 - 5935, ISSN: 0005728144 * |
| SINGH B.G.ET AL.: "In silico investigation on the binding of organoselenium compounds with target proteins of SARS-CoV-", CHEMRXIV, JPN6021017782, 2 July 2020 (2020-07-02), ISSN: 0005728142 * |
| 山下倫明: "魚類に豊富に含まれる「セレン」新型コロナウイルスにも有効", 養殖ビジネス, vol. 57, no. 10, JPN6021017787, 1 October 2020 (2020-10-01), pages 62 - 67, ISSN: 0005728145 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202302093A (zh) | 2023-01-16 |
| JP7837513B2 (ja) | 2026-03-31 |
| TWI911391B (zh) | 2026-01-11 |
| US20250352517A1 (en) | 2025-11-20 |
| WO2022177029A1 (ja) | 2022-08-25 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230721 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241216 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251111 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260109 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260210 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260310 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7837513 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |